DocDollars

Alk-Abello, Inc

TX · United States · Reporting entity ID 100000010705

Total reported 2019–2025
$3.54M
#830 of 2,960 reporting companies — 0% of all reported industry payments
$2.34M in general payments across 36,333 records, plus $1.20M in research funding across 751 records.

How it breaks down

General payments $2,340,620
Research funding $1,196,106

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Alk-Abello, Inc reported $3.54M to US doctors and teaching hospitals from 2019 to 2025, ranking #830 of 2,960 reporting companies. 34% of that was research funding and 66% general payments such as consulting, speaking, food and travel. 36,333 general payment records and 751 research records were filed.

Common questions about Alk-Abello, Inc

How much has Alk-Abello, Inc paid US doctors?

Alk-Abello, Inc reported $3,536,726 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,340,620 in general payments, $1,196,106 in research funding.

How does Alk-Abello, Inc rank among drug and device companies?

It ranks #830 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Alk-Abello, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.